A Canadian government decision to override the patent for the anti-anthrax drug Cipro and buy a generic version brought threats Friday of possible legal action from the antibiotic's maker, Bayer AG. In the United States, officials have said they have the right to override a similar Bayer patent on Cipro, but Bayer has promised to triple production of the drug to meet U.S. government needs.
October 19, 2001 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
The New York Law Journal honors attorneys and judges who have made a remarkable difference in the legal profession in New York.
This conference brings together the industry's most influential & knowledgeable real estate executives from the net lease sector.
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
We are seeking a lawyer with a minimum of four years of experience in transactional work to join our well-established, nationally renowned C...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
Shipman & Goodwin LLP is seeking two associates to expand our national commercial real estate lending practice. Candidates should have ...
Riker Danzig deeply mourns the passing of our esteemed partner, dear friend and beloved colleague, Marc D'Angiolillo.
